ALRGN Bio's Debt Round

ALRGN Bio raised a round of funding on June 23, 2016.

Alrgn Bio combines its patented food grade enzymatic process with current food industry processing equipment to inactivate peanut allergens. The resulting reduced allergen peanuts have the potential t…

Articles about ALRGN Bio's Debt Round: